EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutationsMichael T. McCabe, Caretha L. Creasy, Louis V. LaFrance et al.|Nature|2012Cited by 1.8k
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLCHelai P. Mohammad, Ryan G. Kruger, Kimberly N. Smitheman et al.|Cancer Cell|2015Cited by 518
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2Sharad K. Verma, William H. Miller, Xinrong Tian et al.|ACS Medicinal Chemistry Letters|2012Cited by 377
Inhibition Of LSD1 As a Therapeutic Strategy For The Treatment Of Acute Myeloid LeukemiaRyan G. Kruger, Peter J. Tummino, Helai P. Mohammad et al.|Blood|2013Cited by 30
Abstract 2939: Discovery and synthesis of highly potent and selective small molecule inhibitors of the histone methyltransferase EZH2Sharad K. Verma, Dash Dhanak, Louis V. LaFrance et al.|Cancer Research|2012Cited by 1